Company to prioritize the clinical development of TNX-103 (oral levosimendan) for the treatment of pulmonary hypertension and heart failure with preserved ejection fraction (PH-HFpEF)PH-HFpEF affects more
Q4 2022 consolidated revenue growth of 14.2% to $21.4 millionFY2022 revenue totaled $80.1 million or growth of ~15%, in line with guidanceFY2023 operating plan to focus on achieving positive Adjusted
Blue Ridge Community College has named high achieving students from 15 counties across western North Carolina to the fall 2022 Dean’s List. These full-time students maintained grade point averages of
FY2022 top line revenue expected to end the year at ~$80 million, in line with previously announced revenue guidanceFY2023 revenue guidance range set between $90 million and $95 million, ending